Ze Yang
Lanzhou, 730000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Emerging mechanisms and targetable pathways in immune checkpoint inhibitor‑associated thyroid dysfunction: From pathogenesis to potential intervention.
Journal: Critical reviews in oncology/hematology
Published: May 12, 2026
Prediction of Lymph Node Metastasis in Papillary Thyroid Cancer Using a Propensity Score-Matching-Based Platelet-to-HDL-C Ratio Plot Model: A Retrospective Cohort Study.
Journal: Journal of stomatology, oral and maxillofacial surgery
Published: February 14, 2026
The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancer.
Journal: Cell death discovery
Published: September 03, 2025
The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment.
Journal: Biomolecules
Published: August 07, 2025
Cancer-associated fibroblasts: The "Achilles' Heel" in thyroid tumor progression and therapy.
Journal: Cellular signalling
Published: July 25, 2025
Oncogenic mutation-driven metabolism-immunity regulatory axis: Potential prospects for thyroid cancer precision therapy.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: May 27, 2025
HSPB1 promotes gastric cancer progression by suppressing PANoptosis.
Journal: Acta histochemica
Published: April 27, 2025
Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer.
Journal: International immunopharmacology
Published: September 23, 2024
Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implications.
Journal: Frontiers in immunology
Published: August 05, 2024
Incomplete ablation of thyroid cancer: Achilles' Heel?
Journal: BMC endocrine disorders
Published: May 21, 2024
Last Updated: 09/26/2026